Co-Regulated Expression of TGF-? Variants and miR-21 In Bladder Cancer
Vol. 10 No. 3 (2013),
26 September 2013
AbstractPurpose: To investigate a potential alteration in the expression levels of transforming
growth factor β (TGF-β) and miR-21 in bladder cancer tissues.
Material and Methods: Using real-time polymerase chain reaction (PCR) method, we
examined a potential correlated expression of miR-21 and TGF-β variants in 30 bladder
tumors and their marginal/non-tumor biopsy specimens obtained from the same patients.
Results: Our data revealed a significant down-regulation of TGF-β variants (P = .03) along
with a non-significant alteration in the expression of miR-21 in tumor vs. non-tumor samples.
However, in contrast to low-grade tumors, the expression of miR-21 was upregulated
in high-grade ones, and the expression level can efficiently discriminate low-grade tumors
from high-grade ones (P = .03).
Conclusion: In accordance to the observed similarity between TGF-β variants and miR-21
gene expression alterations in bladder tumors, treating 5637 bladder cancer cell line with
TGF-β recombinant protein caused a significant upregulation of miR-21. The later finding
further confirmed a correlated expression of TGF-β and miR-21 in bladder tumors.
How to Cite
Monfared, H., Ziaee, S. A. M., Hashemitabar, M., Khayatzadeh, H., Kheyrollahi, V., Tavallaei, M., & Mowla, S. J. (2013). Co-Regulated Expression of TGF-? Variants and miR-21 In Bladder Cancer. Urology Journal, 10(3), 981–987. https://doi.org/10.22037/uj.v10i3.1487
- Abstract Viewed: 290 times
- PDF Downloaded: 171 times